Cargando…

Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma

Genetic and epigenetic changes in the von Hippel-Lindau (VHL) tumour suppressor gene are common in sporadic conventional (clear cell) renal cell carcinoma (ccRCC). The effects on VHL expression are unknown but increased understanding may be relevant clinically, either in terms of prognosis or in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	TAYLOR, CLAIRE, CRAVEN, RACHEL A., HARNDEN, PATRICIA, SELBY, PETER J., BANKS, ROSAMONDE E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583750/ https://www.ncbi.nlm.nih.gov/pubmed/22825683 http://dx.doi.org/10.3892/ijo.2012.1561

Ejemplares similares

VHL-dependent regulation of a β-dystroglycan glycoform and glycogene expression in renal cancer
por: AGGELIS, VASSILIS, et al.
Publicado: (2013)

CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
por: McRonald, Fiona E, et al.
Publicado: (2009)

Consequences of VHL Loss on Global DNA Methylome
por: Robinson, Claire M., et al.
Publicado: (2018)

Identification of 3 novel VHL germ-line mutations in Danish VHL patients
por: Dandanell, Mette, et al.
Publicado: (2012)

Delayed Cardiac Metastasis from Renal Cell Carcinoma Caused by VHL Mutation
por: Sudduth, Christopher L., et al.
Publicado: (2023)

Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations
por: Shen, H.-C. Jennifer, et al.
Publicado: (2009)

Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
por: Razafinjatovo, Caroline, et al.
Publicado: (2016)

Trichloroethylene exposure and somatic mutations of the VHL gene in patients with Renal Cell Carcinoma
por: Charbotel, Barbara, et al.
Publicado: (2007)

VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions
por: Mathó, Cecilia, et al.
Publicado: (2022)

Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma
por: Gemmill, R M, et al.
Publicado: (2005)

Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors
por: Szegedi, Krisztián, et al.
Publicado: (2023)

Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
por: Albers, Joachim, et al.
Publicado: (2013)

Computational and Experimental Characterization of dVHL Establish a Drosophila Model of VHL Syndrome
por: Shmueli, Merav D., et al.
Publicado: (2014)

ZBRK1, a novel tumor suppressor, activates VHL gene transcription through formation of a complex with VHL and p300 in renal cancer
por: Chen, Ke, et al.
Publicado: (2015)

The Most Common VHL Point Mutation R167Q in Hereditary VHL Disease Interferes with Cell Plasticity Regulation
por: Buart, Stéphanie, et al.
Publicado: (2021)

The VHL-dependent regulation of microRNAs in renal cancer
por: Neal, Calida S, et al.
Publicado: (2010)

VHL-deficiency leads to reductive stress in renal cells
por: Vellama, Hans, et al.
Publicado: (2023)

Expression of Von Hippel – Lindau (VHL) gene mutation in diagnosed cases of renal cell carcinoma
por: Shahzad, Humera, et al.
Publicado: (2014)

Loss of Von Hippel–Lindau (VHL) Tumor Suppressor Gene Function: VHL–HIF Pathway and Advances in Treatments for Metastatic Renal Cell Carcinoma (RCC)
por: Kim, Hyunho, et al.
Publicado: (2021)

AB175. The first large-scale study of VHL gene mutation spectrum and genotype-phenotype correlationship of VHL disease in China
por: Peng, Shuanghe, et al.
Publicado: (2015)

A multinodular goiter as the initial presentation of a renal cell carcinoma harbouring a novel VHL mutation
por: Bugalho, Maria João M, et al.
Publicado: (2006)

Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors
por: Moore, Lee E., et al.
Publicado: (2011)

Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines
por: Wang, Xuechun, et al.
Publicado: (2022)

Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene
por: Wykoff, C C, et al.
Publicado: (2004)

Biostatistics of VHL-Gene Transfection in the Health Informatics Analysis of Renal Cell Carcinoma
por: Gong, Yunxiang, et al.
Publicado: (2022)

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
por: Hu, Junhui, et al.
Publicado: (2023)

Combined Vhl, Trp53 and Rb1 mutation causes clear cell renal cell carcinoma in mice
por: Harlander, Sabine, et al.
Publicado: (2017)

Playing Tag with HIF: The VHL Story
por: Leung, Sherri K., et al.
Publicado: (2002)

Hypercalcemia in Pheochromocytoma: From MEN to VHL
por: Mittal, Madhukar, et al.
Publicado: (2021)

Von Hippel–Lindau (VHL) small-molecule inhibitor binding increases stability and intracellular levels of VHL protein
por: Frost, Julianty, et al.
Publicado: (2021)

AB174. VHL protein: a new therapeutic target of renal cell carcinoma
por: Wang, Jiangyi, et al.
Publicado: (2015)

VHL-dependent alterations in the secretome of renal cell carcinoma: Association with immune cell response?
por: Stehle, Franziska, et al.
Publicado: (2015)

CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma
por: Schokrpur, Shiruyeh, et al.
Publicado: (2016)

Correlation analysis of VHL and Jade-1 gene expression in human renal cell carcinoma
por: Xiao-fen, Wu, et al.
Publicado: (2016)

Cytosine 5-hydroxymethylation regulates VHL gene expression in renal clear cell carcinoma
por: Ma, En-Guang, et al.
Publicado: (2017)

An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma
por: Gossage, Lucy, et al.
Publicado: (2014)

HIF2A germline–mutation-induced polycythemia in a patient with VHL-associated renal-cell carcinoma
por: Liu, Qiuli, et al.
Publicado: (2017)

Sporadic hemangioblastomas are characterized by cryptic VHL inactivation
por: Shankar, Ganesh M, et al.
Publicado: (2014)

Comprehensive characterization of Alu‐mediated breakpoints in germline VHL gene deletions and rearrangements in patients from 71 VHL families
por: Vocke, Cathy D., et al.
Publicado: (2021)

Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes
por: Büscheck, Franziska, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7oilhc6bmpd2aooisl0j7itr5p